Vaccinex, Inc. (VCNX)
OTCMKTS · Delayed Price · Currency is USD
1.250
+0.470 (60.26%)
Aug 19, 2026, 3:08 PM EST
Vaccinex Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 1.11 | 1.54 | 6.39 | 8.59 | 10.6 |
Cash & Short-Term Investments | 1.11 | 1.54 | 6.39 | 8.59 | 10.6 |
Cash Growth | -27.88% | -75.98% | -25.59% | -18.94% | 281.70% |
Receivables | 0.84 | 0.96 | 0.18 | - | 0.16 |
Prepaid Expenses | 0.59 | 0.85 | 0.91 | 0.82 | 0.53 |
Total Current Assets | 2.53 | 3.35 | 7.48 | 9.41 | 11.29 |
Property, Plant & Equipment | 0.07 | 0.28 | 0.5 | 0.44 | 0.42 |
Total Assets | 2.6 | 3.63 | 7.98 | 9.84 | 11.7 |
Liabilities
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Accounts Payable | 3.96 | 2.04 | 1.52 | 1.06 | 3.17 |
Accrued Expenses | 1.1 | 1.24 | 0.78 | 0.98 | 1.94 |
Short-Term Debt | - | - | - | - | 8.07 |
Current Portion of Long-Term Debt | 0.03 | 0.08 | 0.07 | 0.07 | - |
Current Portion of Leases | - | 0.15 | 0.16 | 0.14 | - |
Current Unearned Revenue | - | 0.06 | - | - | - |
Other Current Liabilities | - | 2.35 | - | - | - |
Total Current Liabilities | 5.08 | 5.92 | 2.54 | 2.26 | 13.18 |
Long-Term Debt | - | 0.03 | 0.1 | 0.18 | 1.13 |
Long-Term Leases | - | - | 0.15 | - | - |
Total Liabilities | 5.08 | 5.94 | 2.78 | 2.43 | 14.31 |
Shareholders' Equity
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Common Stock | 0 | - | - | 0 | 0 |
Additional Paid-In Capital | 354.42 | 337.63 | 324.88 | 307.28 | 250.91 |
Retained Earnings | -358.56 | -339.93 | -319.68 | -299.86 | -277.48 |
Treasury Stock | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
Total Common Equity | -4.15 | -2.31 | 5.19 | 7.41 | -26.58 |
Minority Interest | - | - | - | - | 23.96 |
Shareholders' Equity | -2.49 | -2.31 | 5.19 | 7.41 | -2.61 |
Total Liabilities & Equity | 2.6 | 3.63 | 7.98 | 9.84 | 11.7 |
Additional Metrics
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Total Debt | 0.03 | 0.25 | 0.49 | 0.39 | 9.21 |
Net Cash (Debt) | 1.08 | 1.29 | 5.91 | 8.2 | 1.39 |
Net Cash Growth | -15.99% | -78.19% | -27.97% | 490.71% | -50.00% |
Net Cash Per Share | 0.52 | 2.78 | 29.23 | 59.68 | 15.52 |
Filing Date Shares Outstanding | 2.68 | 1.23 | 0.24 | 0.2 | 0.14 |
Total Common Shares Outstanding | 2.68 | 0.89 | 0.24 | 0.15 | 0.11 |
Working Capital | -2.55 | -2.57 | 4.94 | 7.15 | -1.89 |
Book Value Per Share | -1.55 | -2.59 | 21.86 | 50.53 | -249.28 |
Tangible Book Value | -4.15 | -2.31 | 5.19 | 7.41 | -26.58 |
Tangible Book Value Per Share | -1.55 | -2.59 | 21.86 | 50.53 | -249.28 |
Machinery | 3.97 | 3.95 | 4.19 | 4.13 | 4.12 |
Leasehold Improvements | 3.28 | 3.28 | 3.26 | 3.21 | 3.17 |